Zarka, J., Becker, N., Gicobi, J., Tabiim, A., Jang, A., Heath, E. I., Sartor, A. O., Lucien, F., Childs, D. S., Park, S. S., Ager, C., Andrews, J., Kase, A. M., Ballman, K. V., Yu, N. Y., Vargas, C. E. C., Chaudhuri, A. A., Kim, Y., Cheville, J., Orme, J. (2026). Dynamic investigator initiated enterprise (DIVINE) in prostate cancer: Randomized phase II trial of stereotactic body radiotherapy with or without short-course androgen deprivation and AR pathway inhibition in oligometastatic castration-sensitive prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps283